CorestemChemon Inc.

We take every step carefully, precisely, and constantly.

Most Advanced Stem Cell Therapy for people with #ALS
20+ years of dedication to #Neurodegenerative

[CorestemChemon Inc. @corestemch27286]

Most Advanced Stem Cell Therapy for people with #ALS,
20+ years of dedication to #Neurodegenerative Diseases,
Certified Innovative Pharmaceutical Company by KFDA,

This all leads to one: CorestemChemon.
We take every step carefully, precisely, and constantly.

[CorestemChemon Inc. @corestemch27286]

We're thrilled to announce our participation in BIO International Convention 2024 today!

we're excited to present our new stem cell therapy for ALS and explore potential partnerships for entry into the American market.

Meet us at booth #5407

#BIO2024 #BIOUSA

[CorestemChemon Inc. @corestemch27286]

On June 2nd, World #ALSawarness day, we took part in the Ice Bucket Challenge here in Korea.

Even though we're on opposite sides of the globe, our commitment to battling ALS is as strong as ever.

#ALS #ALSawarenessmonth #icebucketchallenge

[CorestemChemon Inc. @corestemch27286]

While in Korea, members of CorestemCheon ran in a marathon to support ALS patients on June 2nd, World ALS Awareness Day!

It was an incredible opportunity for us to come together and show solidarity with ALS patients worldwide.

#ALSawareness #HopeForALS #LouGehrig

[CorestemChemon Inc. @corestemch27286]

We're proud to announce our participation in the #ALSinDC ALS Community Summit!

We're deeply committed to supporting the ALS community. It was an honor to join forces with incredible individuals and organizations at the I AM ALS event.

#ALSinDC #ALSawareness

[CorestemChemon Inc. @corestemch27286]

CorestemChemon is joining “I AM ALS 2024 Community Summit��� this year!

CorestemChemon US team members will be attend 2024 I AM ALS Community Summit all three days. We are honored and excited to be part of this community.

#ALS #IAMALS

[CorestemChemon Inc. @corestemch27286]

D-2 until "2024 I AM ALS Community Summit"!

CorestemChemon US team members will be attend 2024 I AM ALS Community Summit all three days. We are honored and excited to be part of this historic event.

Livestream: https://t.co/FT503jQNr3

#als #Iamals

[I AM ALS @iamalsorg]

Reminder: subscribe to our YouTube channel and bookmark this link so you can watch the livestream of our Speaker Series! Join us from the National Mall flag event for powerful speeches on May 30th beginning at 10am ET. https://t.co/eOdVxGBmOA

[I AM ALS @iamalsorg]

Reminder: subscribe to our YouTube channel and bookmark this link so you can watch the livestream of our Speaker Series! Join us from the National Mall flag event for powerful speeches on May 30th beginning at 10am ET. https://t.co/eOdVxGBmOA

[CorestemChemon Inc. @corestemch27286]

We are now expecting the phase 3 clinical trial will be finished within this year.

We sincerely hope our findings can improve the lives of the people with ALS and contribute to our understanding of ALS.

#als #alstreatment #clinicaltrials

[CorestemChemon Inc. @corestemch27286]

We could check, once again, that our clinical trial meet the expectations for data acquisition and submission in the near future.

read more at:https://t.co/1iaGPam7M7

[CorestemChemon Inc. @corestemch27286]

We are absolutely excited to announce a major milestone in our phase 3 clinical trial journey!

We have received the IDMCrecommendation to continue the clinical trial of this new ALS treatment without plan modification.

#alstreatment #als #neurodegenerative #clinicaltrials

[CorestemChemon Inc. @corestemch27286]

#als #alsresearch #neurodegenerative #stemcelltherapy

[CorestemChemon Inc. @corestemch27286]

April last year, we started construction of our new GMP at the Osong Bio Complex, Korea. This new center, size of 2,300㎡, will allow us to produce 600 Lot of our stem cell therapy per year.

We will make every effort to provide more opportunities to the patient with ALS.

[CorestemChemon Inc. @corestemch27286]

more detail at:https://t.co/rCRGQ5rV0Y

[CorestemChemon Inc. @corestemch27286]

Last December, we have successfully completed Type-C meeting with FDA regarding on going phase 3 clinical trial of “Neuronata-R”, stem cell therapy for ALS.

read more at:https://t.co/b42e386FTu

#als #alsresearch #neurodegenerative #clinicaltrial

[CorestemChemon Inc. @corestemch27286]

Dedicated to breaking through the boundaries of neuro-degenerative diseases for over 20 decades, we will continue to strive for innovation.

[CorestemChemon Inc. @corestemch27286]

Flashback#2023
Last year, we have completed the patient enrollment 100% for the phase 3 clinical trial of stem cell therapy for FDA. The data of total 126 patients will be collected, analyzed, and finally published in the near future.

#ALS #Neurodegenerative #Phase3 #alsresearch

[CorestemChemon Inc. @corestemch27286]

#als #neurodegenerative

[CorestemChemon Inc. @corestemch27286]

Flashback#2023

Last September, we attended #PACTALS 2023 in Kuala Lumpur.

Had meaningful time to collaborate and share our research data with the fellow professionals.

we proudly announced the Post Marketing Surveillance(PMS) Data of 7.5 year-long study with 257 subjects.

[CorestemChemon Inc. @corestemch27286]

Learn more at: https://t.co/hKajq4pVrE